Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
T acute lymphoblastic leukemia in which the blasts have unique immunophenotypic and genetic characteristics suggesting only limited early T-cell differentiation.
Biomarker and diagnostic research for early T cell progenitor acute lymphoblastic leukemia has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.
57 publications have been identified in PubMed for early T cell progenitor acute lymphoblastic leukemia. Research spans Case Report / Case Series (28%), Basic Science / Preclinical (18%), and Diagnostic / Biomarker (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 16 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:56 PM UTC
Laboratory research | 10 | 18% |
Testing and diagnosis research | 8 | 14% |
Research summaries | 7 | 12% |
Other research | 5 | 9% |
Clinical study results | 5 | 9% |
New treatment approaches | 4 | 7% |
Disease patterns and progression | 2 | 4% |
Saft L (2026). [PMID: 41948832](https://pubmed.ncbi.nlm.nih.gov/41948832/). *Am J Clin Pathol*. [Other]
Wong KL (2026). [PMID: 41659863](https://pubmed.ncbi.nlm.nih.gov/41659863/). *Front Immunol*. [Case Report / Case Series]
Murugesan I (2026). [PMID: 42040724](https://pubmed.ncbi.nlm.nih.gov/42040724/). *Indian J Hematol Blood Transfus*. [Other]
Ravi S (2026). [PMID: 41650945](https://pubmed.ncbi.nlm.nih.gov/41650945/). *Int J Lab Hematol*. [Diagnostic / Biomarker]
Edgar NU (2026). [PMID: 41177979](https://pubmed.ncbi.nlm.nih.gov/41177979/). *Pediatr Blood Cancer*. [Other]
Liu M (2026). [PMID: 41638199](https://pubmed.ncbi.nlm.nih.gov/41638199/). *Cell Rep Med*. [Basic Science / Preclinical]
Song JK (2026). [PMID: 42025216](https://pubmed.ncbi.nlm.nih.gov/42025216/). *Cancer Res Treat*. [Clinical Trial Publication]
Biswas D (2026). [PMID: 41717956](https://pubmed.ncbi.nlm.nih.gov/41717956/). *Indian J Pathol Microbiol*. [Diagnostic / Biomarker]
Ribera JM (2026). [PMID: 42081455](https://pubmed.ncbi.nlm.nih.gov/42081455/). *Blood*. [Basic Science / Preclinical]
Zhizhuo H (2026). [PMID: 41496266](https://pubmed.ncbi.nlm.nih.gov/41496266/). *Cancer Treat Res Commun*. [Clinical Trial Publication]